Proteomic profiling of gemcitabine-resistant pancreatic cancer cells unravels microtubule-associated protein 2 overexpression, that correlated to poorer survival but also to increased sensitivity to nab-paclitaxel
AISP 2019, Verona 21 September 2019
Presentation by Mjriam Capula, who was awarded for the Best Oral Presentation in preclinical/translational research
Some results of this study have been published in Therapeutic Advances in Medical Oncology:
www.ncbi.nlm.nih.gov/pmc/articles/10.1177_1758835919841233.pdf
PDF file: Mjriam Capula – Presentazione AISP 2019
